Kelly O'Halloran
Pharmaceutical companies must walk their drugs through a four-phase approval process before they hit the market. It’s an incredibly lengthy undertaking (think six to 11 years) and can cost drug developers tens of millions of dollars in clinical trials. But an Austin startup named Litmus Health is intervening to help pharmaceutical businesses during the clinical process through the use of data and technology.
